Sun Yat-sen University Cancer Center (SYSUCC)

Sun Yat-sen University Cancer Center (SYSUCC) is a university-affiliated cancer hospital. Established in 1964, it is one of China's earliest specialized tumor centers. The hospital operates across two campuses in Guangzhou, in the Yuexiu and Huangpu districts. A third campus in Tianhe is currently in planning.

Accreditations and Clinical Volume

The center has held UICC membership since 2012. It was recognized as a Tertiary Class A Hospital in 1994. The hospital houses the State Key Laboratory of Oncology in South China. Its radiation therapy and general surgery departments hold national clinical specialty status.

SYSUCC manages a very high patient volume. In 2023, the center recorded over 1.84 million outpatient visits and 185,408 inpatient stays. The surgical team performed 45,492 procedures that year.

Oncology Specialties and Methods

The center has 35 clinical departments focused on complete cancer care. These range from prevention and screening to advanced surgical and medical treatments.

Neurosurgery and Brain Tumor Care

The neurosurgery department treats benign and malignant central nervous system tumors. The team includes 13 neurosurgeons and specialized neuro-oncologists. They see more than 2,000 new brain tumor patients each year. Key conditions treated:

• Glioma and meningioma
• Pituitary and skull base tumors
• Pediatric brain tumors
• Metastatic brain cancer

The team performs around 1,400 neurosurgical procedures annually. CyberKnife radiosurgery and proton-beam therapy are available. These allow precise radiation delivery to complex brain structures.

Hematological Oncology

The hematology department specializes in blood cancers. It was one of the first chemotherapy units for these conditions. Specialists provide CAR-T cell immunotherapy for lymphoma and leukemia. This therapy uses the patient's own immune cells to fight cancer.

For lymphoma, the center offers high-dose chemotherapy with autologous stem cell rescue. This restores healthy blood cells after intensive treatment. The team treats both Hodgkin and non-Hodgkin lymphoma subtypes.

Urology and Genitourinary Surgery

The urology department focuses on cancers of the urinary and reproductive systems. Surgeons use da Vinci robotic systems for prostate and kidney procedures. Robotic techniques mean smaller incisions and better precision than open surgery. The department covers:

• Bladder and prostate cancer
• Kidney and adrenal gland tumors
• Testicular and penile cancer
• Ureter and urethra tumors

Surgeons also perform minimally invasive laparoscopic procedures. These techniques help manage tumors while preserving organ function when possible.

Diagnostic and Treatment Technology

The center operates 42 surgery rooms and maintains 2,247 ward beds. It was among the first Chinese cancer hospitals to adopt digital pathology. This improves the accuracy of tissue analysis for diagnosis.

The nuclear medicine department provides PET/CT and SPECT imaging for tumor staging. It produces its own radionuclides for therapy. Four da Vinci robots are available across the two campuses.

Specialized diagnostic equipment includes PET-CT with Gallium 68 and Fluoromisonidazole tracers. These help identify specific tumor types and biological characteristics. The hospital also uses HIFU ablation – a non-invasive method that destroys tumors with focused ultrasound.

International Patient Services

The International Medical Center supports foreign patients. The team coordinates diagnosis and treatment plans aligned with international standards. Services begin before patients arrive in China:

• Treatment planning prior to arrival
• Translation of medical files from Chinese to English
• Full-cycle health management
• Daily treatment coordination

This department maintains continuous care between international patients and clinical teams.